Effects of ketoconazole on ovarian response in patients with polycystic ovarian syndrome: A double blind randomized clinical trial
,
Abstract
Objective: The study assessed the efficacy of low dose ketoconazole in addition to clomiphene citrate (CC) and hMG on ovulation induction.
Materials and methods:A double blind, randomized, clinical trial was performed on fifty infertile patients with PCOS who had failed to respond to a daily dose of hMG and 100 mg CC for controlled ovarian hyperstimulation in Vali-e-Asr Reproductive Health Research Center.These patients were randomly divided into two equal groups receiving ketoconazole or placebo.All patients received CC and hMG for controlled ovarian hyperstimulation.Number of mature follicles, estradiol and progesterone levels at the time of hCG adminstration, endometrial thickness, ovarian hyperstimulation syndrome(OHSS), pregnancy rate, abortion, multiple pregnancies were measured. SPSS 11 software was used for statistical analysis. Statistical significance was defined as P < 0.05.
Results: No significant statistical differences existed in the number of mature follicles, estradiol and progesterone levels prior to hCG administration ,endometrial thickness, OHSS and pregnancy rate between two groups. Estradiol level was lower among those receiving ketoconazole. No abortion and multiple pregnancy were found.
Conclusion: Ketoconazole may suppress steroid production in resistant PCOS patients undergoing CC and hMG induction. But it has no effects on follicular maturation and OHSS prevention.
-Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Baltimore: Lippincott Williams & Wilkins, 2005.
-Berek JS, Adashi EY, Hillard PA. Novak's Gynecology. 13th ed. Baltimore: Lippincott Williams & Wilkins, 2002.
-Frank S. Polycystic ovarian syndrome. N Eng L J Med 1995; 333: 853-861.
-Greenblatt RB, Barfield WE, Jungck EC, Ray AW. Induction of ovulation with MRL/41. Preliminary report. JAMA 1961; 178: 101-106.
-Hughes E, Collins J, Vandekerckhove P. Clomiphene citrate for ovulation induction in women with oligoamenorrhea. Cochrane Database Sys Rev 2001; 4. The Cochrane Library. Oxford Update software.
-Ali Hassan H, El-Gezeiry D, Nafaa TM, Baghdadi I. Improved responsiveness of PCOS patients to clomiphene after CYP17a inhibitor. J Assist Reprod Genet 2001; 18: 608-611.
-Ron-El R. Complications of ovulation induction. Baillieres Clin Obstet Gynecol 1993; 7: 435-453.
-Schenker JG, Ezra Y. Complications of assisted reproductive techniques. Fertil Steril 1994; 61: 411-422.
-Vidal-puig AJ, Munos-Torres M, Joder-Gimento E, Garcia-Calvente CJ, Lardelli P, Ruiz-Requera ME et al. Ketoconazole therapy: hormonal and clinical effects in nontumoral hyperandrogenism. Eur J Endocrinol 1994; 130: 333-338.
-Gal M, Orly J, Barr I, Algur N, Boldes R, Diamant YZ. Low dose ketoconazole attenuates serum androgen levels in patients with polycystic ovarian syndrome and inhibits ovarian steroidogenesis in vitro. Fertil Steril 1994; 61: 823-832.
-L Sik A, Gokmen O, Zeyneloglu HB, Senoz S, Zorlu CG. Low dose ketconazole is an effective and relatively safe alternative in the treatment of hirsutism. Aust N Z J Obstet Gynecol 1996; 36: 487-489.
-Pepper G, Brenner SH, Gabrilove JL. Ketoconazole use in the treatment of ovarian hyperandrogenism. Fertil Steril 1990; 54: 438-444.
-Trachtenberg J, Zadra J. Steroid synthesis inhibition by ketoconazole: sites of action. Clin Invest Med 1988; 11: 1-5.
-Pont A, Williams PL, Azhar S, Garcia-Calvente CJ, Lardelli P, Ruiz-Requera ME et al. Ketoconazole blocks testosterone synthesis. Arch Intern Med 1982; 142: 24-29.
-Harris AL, Cantwell BM, Dowsett M. High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer. Br J Cancer 1988; 58:493-496.
-Santen RJ, Van den Bossche H, Symoens J, DE Coster R. Site of action of low dose ketoconazole on androgen biosynthesis in men. J Clin Endocrinal Metab 1983; 57: 732-736.
-De Coster R, Mohler C, Denis L, Coene MC, Caers I, Amery W et al. Effects of high dose ketoconazole and dexamethazone on ACTH-stimulated adrenal steroidogenesis in orchiectomized prostatic cancer patients. ACTA Endocrinol 1987; 115: 265-241.
-Gal M, Eldar-Geva T, Margalioth EJ, Barr I, Orly J, Diamant YZ. Attenuation of ovarian response by low-dose ketoconazole during superovulation in patients with polycystic ovarian syndrome. Fertil Steril 1999; 72: 26-31.
-Tasfiri A, Popliker M, Nahum R, Beyth Y. Effects of ketoconazole on ovulatory changes in the rat: implications on the role of meiosis activating sterol. Mol Hum Reprod 1998; 4: 483-489.
-Parsanezhad ME, Alborzi S, Pakniat M, Schmidt EH. A double blind randomized, placebo controlled study to assess the efficacy of ketoconazole for reducing the risk of ovarian hyperstimulation syndrome. Fertil Steril 2003; 80: 1151-1155.
-Pritts EA. Treatment of infertile patient with polycystic ovarian syndrome. Obstet Gynecol Sur 2002; 57: 587-597.
-Limbard LE, Hardman JG, Gilman AG. Goodman and Gilman’s the pharmalogical basis of therapeutics.10th ed. New York: MC Grow Hill, 2001.
| Files | ||
| Issue | Vol 1, No 1 (September 2007) | |
| Section | Original Articles | |
| Keywords | ||
| ovulation induction ovarian hyperstimulation syndrome ovarian steroid production | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
